Medicine and Dentistry
Bladder Cancer
100%
Cystectomy
100%
Lymph Node
66%
Hazard Ratio
66%
Disease Specific Survival
66%
Recurrence Free Survival
66%
Prognostic Factor
50%
Multivariate Analysis
33%
Cancer
16%
Prospective Study
16%
Bladder
16%
Transitional Cell Carcinoma
16%
Survival Rate
16%
Lymph Node Metastasis
16%
Adjuvant Chemotherapy
16%
Pelvis Lymphadenectomy
16%
Keyphrases
Bladder Cancer
100%
Node-positive
100%
Extranodal Extension
100%
Radical Cystectomy
50%
Hazard Ratio
33%
Disease-specific Survival
33%
Recurrence-free Survival
33%
Multivariate Analysis
16%
Positive Lymph Nodes
16%
Independent Prognostic Factor
16%
Lymph Node Ratio
16%
Significant Predictors
8%
Consecutive Patients
8%
Prognostic Factors
8%
Lymph Node Metastasis
8%
Upper Tract Urothelial Carcinoma
8%
Tertiary Hospital
8%
Adjuvant Chemotherapy
8%
Prognostic Information
8%
Nodal Status
8%
Pelvic Lymphadenectomy
8%
Histological Examination
8%
Recurrence Prediction
8%
Urological Malignancies
8%
Prognostic Role
8%
Contradictory Results
8%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
Recurrence Free Survival
66%
Disease Specific Survival
66%
Prospective Study
16%
Chemotherapy
16%
Survival Rate
16%
Transitional Cell Carcinoma
16%
Lymph Node Metastasis
16%